MSB 2.75% $1.06 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-380

  1. 2,293 Posts.
    lightbulb Created with Sketch. 450
    The shorts have been spot on since ODAC vote, 3 years ago?
    I don’t short, but it is worth observing the alignment.
    If I might say, to the point that its as if they are in on the board meetings, inner circle kind of thing.
    No proof, but definitely running parallel to the share price.
    Big pharma need their pound of flesh one way or another I suppose.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.06
Change
-0.030(2.75%)
Mkt cap ! $1.244B
Open High Low Value Volume
$1.10 $1.11 $1.05 $1.636M 1.522M

Buyers (Bids)

No. Vol. Price($)
6 13270 $1.06
 

Sellers (Offers)

Price($) Vol. No.
$1.06 38021 12
View Market Depth
Last trade - 10.43am 14/06/2024 (20 minute delay) ?
Last
$1.07
  Change
-0.030 ( 1.94 %)
Open High Low Volume
$1.09 $1.11 $1.06 303854
Last updated 11.00am 14/06/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.